Volume 5, Number 4, 1 December 2003

Clinical Trials in Children

pp. 174-174(1)
Author: Choonara I.

Clinical Trials in Children and Healthy Volunteers. Quality and Characteristics of Notifications Reviewed by the Regulatory Agency in Finland

pp. 175-182(8)
Authors: Keinonen T.; Miettinen P.; Saano V.; Ylitalo P.

Clinical Trials, Ethical Issues and Patient Recruitment: an Australian Perspective

pp. 183-187(5)
Authors: Lim A.; Cranswick N.

First International Workshop on Paediatric and Perinatal Drug Therapy and Paediatric Clinical Trials

pp. 188-189(2)

Population Pharmacokinetics of Nalbuphine in Neonates

pp. 190-198(9)
Authors: Jacqz-Aigrain E.; Debillon T.; Daoud P.; Boithias C.; Hamon I.; Rayet I.; Popon M.; Mentré F.

Trends in Paediatric Pharmacology and Toxicology

pp. 199-201(3)
Author: Kearns G.L.

Flumazenil Use in Children

pp. 202-209(8)
Authors: Aviram E.E.; Ben-Abraham R.; Weinbroum A.A.

Continuous Intravenous Infusion of Omeprazole in the Management of an Upper Gastrointestinal Bleed in an Infant

pp. 210-211(2)
Authors: Ashtekar C.S.; Vyas H.; Stewart R.J.; Newman C.

Myotoxicity Induced By Clonazepam: A Case Report

pp. 214-216(3)
Authors: Gupta R.; Appleton R.E.

Neonatal and Paediatric Pharmacists Group, 9th Annual Conference

pp. 217-218(2)